NCT06741085View on ClinicalTrials.gov

A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain

PHASE2RecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

December 13, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Non Small Cell Lung Cancer Metastatic
Interventions
DRUG

osimertinib

oral EGFR-TKI

RADIATION

stereotactic radiosurgery (SRS)

"0-20mm-18Gy x 1, 21Gy x 1 ,9Gy x 3~20mm or larger- 9Gy x 3, 6Gy x 5, 5Gy x 5"

Trial Locations (8)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

10604

RECRUITING

Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison

11553

RECRUITING

Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre

11725

RECRUITING

Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack

33143

RECRUITING

BAPTIST ALLIANCE - MCI (Data Collection Only), Miami

07920

RECRUITING

Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge

07748

RECRUITING

Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown

07645

RECRUITING

Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER